Healio

Medium-dose inhaled corticosteroid plus LABA best for pediatric uncontrolled asthma

Please provide your email address to receive an email when new articles are posted on . Moving from a low-dose inhaled corticosteroid to a medium-dose inhaled corticosteroid plus a long-acting beta ...
Business Wire

Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment

Phase 2b study to evaluate novel inhaled therapeutic in patients with inadequately controlled asthma despite medium-to-high dose ICS/LABA therapy BOSTON--(BUSINESS WIRE)--Kinaset Therapeutics, a ...
Hosted on MSN

Triple Therapy Inhaler Improves Lung Function in Poorly Controlled Asthma

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...
Healio

KALOS, LOGOS: Triple therapy inhaler improves lung function in asthma

Please provide your email address to receive an email when new articles are posted on . Two doses of budesonide/glycopyrrolate/formoterol fumarate improved lung ...
The Globe and Mail

AstraZeneca’s AZD4604: Promising Results in Asthma Treatment Study

In a recent clinical study update, AstraZeneca has completed a Phase 2a study titled ‘A Phase 2a Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AZD4604 Twice ...